TRANSITION ZONE PROSTATE SPECIFIC ANTIGEN DENSITY: LACK OF USE IN PREDICTION OF PROSTATIC CARCINOMA-Reference-Cited by-同舟云学术

TRANSITION ZONE PROSTATE SPECIFIC ANTIGEN DENSITY: LACK OF USE IN PREDICTION OF PROSTATIC CARCINOMA

Published:1998-07 Issue:1 Volume:160 Page:77-82
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LIN DANIEL W.¹,GOLD MITCHELL H.¹,RANSOM SEAN¹,ELLIS WILLIAM J.¹,BRAWER MICHAEL K.¹

Affiliation:

1. Department of Urology, University of Washington, Section of Urology, Veteran's Affairs Medical Center and Northwest Prostate Institute, Seattle, Washington

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.;Oesterling;J. Urol.,1991

2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;New Engl. J. Med.,1991

3. Screening for prostatic carcinoma with prostate specific antigen.;Brawer;J. Urol.,1992

4. Screening for prostatic carcinoma with PSA: results of the second year.;Brawer;J. Urol.,1993

5. Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocity.;Carter;Urology,1995

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transition-zone PSA-density calculated from MRI deep learning prostate zonal segmentation model for prediction of clinically significant prostate cancer;Abdominal Radiology;2024-06-19

2. Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”;International braz j urol;2017-04

3. Utility of the transition zone index for identification of prostate cancer in Chinese men with intermediate PSA levels;International Urology and Nephrology;2012-02-05

4. Biomarkers for prostate cancer detection and progression: Beyond prostate-specific antigen;Drug News & Perspectives;2010

5. Beyond PSA: Utility of novel tumor markers in the setting of elevated PSA;Urologic Oncology: Seminars and Original Investigations;2009-05